четверг, 4 февраля 2016 г.

Johnson & Johnson, ViaCyte testing possible diabetes cure

Johnson & Johnson, ViaCyte testing possible diabetes cure


Johnson & Johnson, continuing its long quest for a Type 1 diabetes cure, is joining forces with biotech company ViaCyte to speed development of the first stem cell treatment that could fix the life-threatening hormonal disorder. They've already begun testing it in a small number of diabetic patients.



from Biotech News